🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06695676
Starting soon Observational

Effects of Lurasidone on Left Ventricle Systolic Functions

NCT06695676 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2024-11
Last updated
2024-11-19

Condition(s) studied

Lurasidone CardiotoxicitySchizophrenia PatientsBipolar Disorders

Investigational drug(s) / intervention(s)

Global Longitudinal Strain

Global Longitudinal Strain: Global longitudinal strain measurement is a more objective method to determine left ventricular systolic function than traditional eyeballing method. It helps to detect and quantify subtle changes even so it is an emerging method to evaluate the cardiotoxicity of chemotherapeutic drugs. It is planned to compare each selected patient's GLS measurement before starting to use lurasidone and after six months of using it. Hereby our aim is to find if lurasidone has any effect on left ventricular systolic function.

Study summary

The goal of our study to learn if lurasidone molecule which is used on patients with schizophrenia or bipolar disorder has any cardiotoxic effect.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Aged 18 to 65 years * Diagnosed with schizophrenia or bipolar disorder by the psychiatry clinic of our center and indicated to use lurasidone molecule * Hasn't been diagnosed with coronary artery disease, any kind of heart failure or severe valvular disease Exclusion Criteria: * Patients who do not agree to participate to the trial * Patient who do not meet the inclusion criteria

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Adnan Menderes University Aydin Zafer

More Aydin Adnan Menderes University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06695676 on ClinicalTrials.gov ↗ ← All trials in Turkey